Your browser doesn't support javascript.
loading
Notch1-CD22-Dependent Immune Dysregulation in the SARS-CoV2-Associated Multisystem Inflammatory Syndrome in Children.
Chatila, Talal A; Benamar, Mehdi; Chen, Qian; Chou, Janet; Julé, Amelie; Boudra, Rafik; Contini, Paola; Crestani, Elena; Wang, Muyun; Fong, Jason; Lai, Peggy; Rockwitz, Shira; Lee, Pui; Chan, Tsz Man Fion; Altun, Ekin Zeynep; Kepenekli, Eda; Karakoc-Aydiner, Elif; Ozen, Ahmet; Boran, Perran; Aygun, Fatih; Onal, Pinar; Sakalli, Ayse Ayzit Kilinc; Cokugras, Haluk; Gelmez, Metin; Öktelik, Fatma; Cetin, Esin Aktas; Zhong, Yuelin; Taylor, Maria; Irby, Katherine; Halasa, Natasha; Signa, Sara; Prigione, Ignazia; Gattorno, Marco; Cotugno, Nicola; Amodio, Donato; Geha, Raif; Son, Mary Beth; Newburger, Jane; Agrawal, Pankaj; Volpi, Stefano; Palma, Paolo; Kiykim, Ayca; Randolph, Adrienne; Deniz, Gunnur; Baris, Safa; De Palma, Raffaele; Schmitz-Abe, Klaus; Charbonnier, Louis-Marie; Henderson, Lauren.
Affiliation
  • Chatila TA; Boston Children's Hospital - Harvard Medical School.
  • Benamar M; INSERM.
  • Chen Q; Division of Immunology, Boston Children's Hospital, Boston, Massachusetts, USA; Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.
  • Chou J; Childrens Hospital Boston/Harvard Medical School.
  • Julé A; Division of Immunology, Boston Children's Hospital, Boston, Massachusetts, USA; Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.
  • Boudra R; Harvard Medical School.
  • Contini P; University of Genoa.
  • Crestani E; Boston Children's Hospital - Harvard Medical School.
  • Wang M; 1Division of Immunology, Boston Children's Hospital, Boston, Massachusetts, USA; 2Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.
  • Fong J; Boston Children's Hospital.
  • Lai P; Massachusetts General Hospital, Harvard Medical School.
  • Rockwitz S; The Manton Center for Orphan Disease Research, Boston Children's Hospital, Boston, USA.
  • Lee P; Boston Children's Hospital.
  • Chan TMF; 1Division of Immunology, Boston Children's Hospital, Boston, Massachusetts, USA; 2Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.
  • Altun EZ; Ministry of Healthy, Marmara University Education and Training Hospital, Department of Pediatrics, Istanbul, Turkey.
  • Kepenekli E; Marmara University, Faculty of Medicine, Division of Pediatric Infectious Diseases, Istanbul, Turkey.
  • Karakoc-Aydiner E; Marmara University, School of Medicine, Department of Pediatrics, Division of Allergy and Immunology, Istanbul.
  • Ozen A; Marmara University.
  • Boran P; Marmara University, Faculty of Medicine, Division of Social Pediatrics, Istanbul, Turkey.
  • Aygun F; Department of Pediatric Intensive Care, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Onal P; Department of Pediatric Infectious Diseases, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Sakalli AAK; Department of Pediatric Pulmonology, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Cokugras H; Department of Pediatric Infectious Diseases, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey. Department of Pediatric Pulmonology, Cerrahp.
  • Gelmez M; Istanbul University.
  • Öktelik F; Istanbul University.
  • Cetin EA; Istanbul University.
  • Zhong Y; 1Division of Immunology, Boston Children's Hospital, Boston, Massachusetts, USA; 2Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.
  • Taylor M; 1Division of Immunology, Boston Children's Hospital, Boston, Massachusetts, USA; 2Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.
  • Irby K; Arkansas Children's Hospital.
  • Halasa N; Vanderbilt University Medical Center.
  • Signa S; DINOGMI, Università degli Studi di Genova, Genova, Italy and Center for Autoinflammatory Diseases and Immunodeficiencies, IRCCS Istituto Giannina Gaslini, Genova, Italy.
  • Prigione I; Center for Autoinflammatory Diseases and Immunodeficiencies, IRCCS Istituto Giannina Gaslini, Genova, Italy.
  • Gattorno M; Center for Autoinflammatory Diseases and Immunodeficiencies, IRCCS Istituto Giannina Gaslini, Genova, Italy.
  • Cotugno N; Clinical and Research Unit of Clinical Immunology and Vaccinology, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy, Chair of Pediatrics, Department of Systems Medicine, University.
  • Amodio D; Clinical and Research Unit of Clinical Immunology and Vaccinology, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
  • Geha R; Childrens Hospital Boston/Harvard Medical School.
  • Son MB; Boston Children's Hospital.
  • Newburger J; Boston Children's Hospital.
  • Agrawal P; Division of Newborn Medicine and Genetics & Genomics, Department of Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Volpi S; DINOGMI, Università degli Studi di Genova, Genova, Italy and Center for Autoinflammatory Diseases and Immunodeficiencies, IRCCS Istituto Giannina Gaslini, Genova, Italy.
  • Palma P; Clinical and Research Unit of Clinical Immunology and Vaccinology, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy, Chair of Pediatrics, Department of Systems Medicine, University.
  • Kiykim A; Division of Pediatric Allergy and Immunology, Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Randolph A; Boston Children's Hospital.
  • Deniz G; Istanbul University.
  • Baris S; Marmara University, School of Medicine, Department of Pediatrics, Division of Allergy and Immunology, Istanbul.
  • De Palma R; University of Genova.
  • Schmitz-Abe K; 1Division of Immunology, Boston Children's Hospital, Boston, Massachusetts, USA; 2Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.
  • Charbonnier LM; Boston Children's Hospital, Boston.
  • Henderson L; Boston Children's Hospital and Harvard Medical School.
Res Sq ; 2022 Apr 11.
Article in En | MEDLINE | ID: mdl-35441180
ABSTRACT
Multisystem inflammatory syndrome in children (MIS-C) evolves in some pediatric patients following acute infection with SARS-CoV-2 by hitherto unknown mechanisms. Whereas acute-COVID-19 severity and outcome were previously correlated with Notch4 expression on regulatory T (Treg) cells, here we show that the Treg cells in MIS-C are destabilized in association with increased Notch1 expression. Genetic analysis revealed that MIS-C patients were enriched in rare deleterious variant impacting inflammation and autoimmunity pathways, including dominant negative mutations in the Notch1 regulators NUMB and NUMBL. Notch1 signaling in Treg cells induced CD22, leading to their destabilization in an mTORC1 dependent manner and to the promotion of systemic inflammation. These results establish a Notch1-CD22 signaling axis that disrupts Treg cell function in MIS-C and point to distinct immune checkpoints controlled by individual Treg cell Notch receptors that shape the inflammatory outcome in SARS-CoV-2 infection.

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: Res Sq Year: 2022 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: Res Sq Year: 2022 Document type: Article